Last update 30 Aug 2025

RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)

Overview

Basic Info

Drug Type
Prophylactic vaccine, mRNA vaccine
Synonyms-
Target
SARS-CoV-2 S protein
Action
inhibitors
Mechanism
SARS-CoV-2 S protein inhibitors(SARS-CoV-2 S protein inhibitors)
Therapeutic Areas
Infectious DiseasesRespiratory DiseasesOther Diseases
Active Indication
COVID-19Severe Acute Respiratory SyndromeCoronavirus Infections
Inactive Indication-
Originator Organization
Agna Biopharmaceutical Co., Ltd.Guangzhou Medical UniversityGuangzhou Medical UniversityGuangzhou Ribobio Co., Ltd.Guangzhou Ribobio Co., Ltd.
Active Organization
Agna Biopharmaceutical Co., Ltd.Guangzhou Medical UniversityGuangzhou Medical UniversityGuangzhou Ribobio Co., Ltd.Guangzhou Ribobio Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
NCT05903118
/ CompletedPhase 1/2
A Phase I/II, Randomized, Blind, Placebo-Controlled Study to Evaluate the Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (RBMRNA-176) in Healthy Adults Aged 18 Years and Older
100 Clinical Results associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data
100 Translational Medicine associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data
100 Patents (Medical) associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data
100 Deals associated with RBMRNA-176(Guangzhou Medical University/Guangzhou Ribobio/Agna Biopharmaceutical)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2
China
Agna Biopharmaceutical Co., Ltd.
08 Jan 2022
Severe Acute Respiratory SyndromePhase 2
China
Agna Biopharmaceutical Co., Ltd.
08 Jan 2022
Coronavirus InfectionsPreclinical
China
Guangzhou Medical UniversityGuangzhou Medical University
11 Oct 2022
Coronavirus InfectionsPreclinical
China
Guangzhou Ribobio Co., Ltd.Guangzhou Ribobio Co., Ltd.
11 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free